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Etiology determination of neurodevelopmental disabilities (NDDs) currently remains a worldwide common challenge on child
health. We herein reported the etiology distribution feature in a cohort of 285 Chinese patients with NDDs. Although concrete
NDD etiologies in 48.4% of the total patients could not be identiﬁed, genetic diseases (with the proportion of 35.8% in the total
cases) including inborn errors of metabolism (IEM) and congenital dysmorphic diseases, constituted the commonest etiology
category for NDDs in this study. The two key experimental technologies in pediatric metabolomics, gas chromatography-mass
spectrometry (GC-MS), and tandem mass spectrometry (MS-MS), proved to be substantially helpful for the exploration of the
NDD etiologies in this clinical investigation. The ﬁndings in this paper provided latest epidemiologic information on the etiology
distribution of NDDs in Chinese, and the syndromic NDDs caused by citrin deﬁciency and the novel chromosomal karyotype,
respectively, further expanded the etiology spectrum of NDDs.
1.Introduction
With global developmental delay (GDD) and mental retar-
dation (MR) as two main clinical subtypes, neurodevelop-
mental disabilities (NDDs), which are deﬁned as a group
of chronic clinically distinct disorders that all share a
documented disturbance, quantitative, qualitative, or both,
in developmental progress in one or more developmen-
tal domains compared with established norms [1], are
conventionally categorized into syndromic type which is
characterized by associated clinical, radiological, metabolic
orbiologicalfeatures,andnonsyndromictypeinwhichNDD
represents the only manifestation. The precise prevalence of
NDDs remains unclear, but this entity has been estimated to
aﬀect5% to10%ofchildren[2].Indevelopedcountries, MR
has become the most frequent cause of severe handicap in
children and one of the main reasons for referral in clinical
genetic practice [3]. Actually, 1% to 3% of children younger
than 5 years have been reasonably given the prevalence of
MR in a speciﬁc population [4]. As the largest developing
country in the world with a population over 1.3 billion,
China also faces the diﬃcult challenge of NDDs on its child
health. Aninvestigation in theyear2000hasrevealedthatthe
MR incidence in children below 6 years of age was 0.931%,2 Journal of Biomedicine and Biotechnology
and 136,000 children with MR were increased annually in
mainland of our country [5]. Etiology determination of
NDDs was essential not only for the option of therapeutic
imperatives and evaluation of clinical outcomes and recur-
rence risks but also for other beneﬁts including avoidance
of unnecessary tests and access to appropriate patients for
accumulating management experiences, however, this issue
also remains far from resolved at the current stage in
pediatric practice. In this paper, we reported our eight-year
ﬁndings on NDD etiologies in a medical center in south
China.
2.Subjectsand Methods
2.1. Patients. The research subjects recruited in this study
were all patients referred to, from April 2002 to March 2010,
Department of Pediatrics, First Aﬃliated Hospital, Jinan
University, Guangdong, China. The GDD/MR diagnosis in
most cases was made by at least 2 pediatric physicians in
diﬀerent hospitals in accordance with the updated concepts
in the review [1]. For some cases who suﬀered from other
clinical problems such as liver diseases and malformations,
NDD was noticed and then conﬁrmed in our department.
The patients in this study came from 22 provinces, munici-
palities, and autonomous regions in China, respectively, with
most of them from Guangdong Province.
2.2.Clinical Data. History inquiry and physical examination
were performed on all the NDDs patients in our pediatric
clinic or award and the positive ﬁndings were recorded
and preserved by the authors. Most of the laboratory
and imaging results were collected from the correspond-
ing databases in our hospital, besides some provided by
parents of the patients at their referral to the authors
for clinical counseling. In this study we, by means of
a cross-sectional study, retrospectively analyzed and sum-
marised the clinical information collected in the past 8
years.
2.3. Gas Chromatography-Mass Spectrometry (GC-MS).
Selective screening of inborn errors of metabolism (IEMs)
in this study was conducted by analysis of the urinary com-
ponents, using an urease pretreatment GC-MS procedure,
mainly with a Finnigan GC-MS instrument (TRACE DSQ),
with detailed information described previously by our group
[6].
2.4. Tandem Mass Spectrometry (MS-MS). Amino and acyl
carnitine in dried blood stains was analyzed by means of
a MS-MS procedure, and sample preparation, apparatus
settings, and data analysis were based on the detailed
information described in [7]. The analysis was conducted
withanAPI3200tandemmassspectrometerpurchased from
Applied Biosystems. Neutral loss scan and precursor scan
were used for the analysis of most amino acids and acyl
carnitines, respectively, while multiple reaction monitoring
(MRM) was utilized for the detection of glycine, ornithine,
arginine, and citrulline as well.
Table 1: Main clinical manifestations besides NDDs and the
positive laboratory and imaging ﬁndings in syndromic NDDs.
No. Positive ﬁndings Cases
01 Failure to thrive 81
02 Seizure/convulsion 37
03 Hearing disability 28
04 Dysmorphic facial features 25
05 Abnormalurine odor 20
06 Eye movement obstacles 19
07 Vomitting 18
08 Hair depigmentation 15
09 Microcephaly 11
10 Skin abnormalities 10
11 Hepato/splenomegaly 10
12 Impaired swallowingand chewing 5
13 Fondus ocili abnormalities 4
14 Vision problem 4
15 Abnormallens 3
16 Genitalia malformation 3
17 Metabolic acidosis 46
18 Hyperammonemia 12
19 AbnormalEEG 22
20 Skeleton abnormality on X ray 5
21 CT/MRI abnormalﬁndings 85
2.5. Chromosome Karyotype Analysis. Traditional chromo-
somal banding was performed in NDD patients suspected
to have chromosomal abberations. Fluorescence in situ
hybridization (FISH) was further used, when necessary, to
determine the complex karyotypes as previously described
[8]. Brieﬂy, the peripheral blood lymphocytes were cul-
tured under phytohemagglutinin (PHA) stimulation and
treated with colcemid and harvested by standard methods.
Metaphases were spread on clean slides, and standard G-
banding with trypsin-Giemsa was performed. The slides
for FISH were stored at −20◦Cb e f o r eu s e .T h ed e n a t u r e d
FISH probe (Abbott-Vysis, Downers Grove, IL, USA) was
added to the denatured slides with metaphase spreads in a
moist chamber for hybridizing over night. After washing,
the slide was counterstained with DAPI in an antifade
solution. The hybridized metaphase chromosomes were
captured and analyzed using a digital image analysis system
containing an Olympus BX51 microscope equipped with
LUCIA Cytogenetics system (Prague, Czech Repuplic).
2.6. SLC25A13 Gene Mutation Analysis. The diagnosis of
citrin deﬁciency was conﬁrmed by mutation analysis of the
causative gene SLC25A13. Four hotspot mutations, 851-
854del(851del4), IVS6 + 5G > A, IVS16ins3kb, and 1638-
1660dup were screened by means of the routine approaches
described in reference [9]. In this study, the sequences of the
forward and backward primers for PCR ampliﬁcation of the
mutation 851del4 were 5 -ggtatatttgttgcttgtgtttg-3  and 5 -
tcttccagaggagcaatccg-3 , respectively.Journal of Biomedicine and Biotechnology 3
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Figure1:ChemicaldiagnosisofglutaricacidemiatypeIbyGC-MS analysisofurinarymetabolitesfora9-month-oldfemalewithmotorand
language retardation. Figure 1(a) is a representative GC-MS total ion current (TIC) proﬁle, in which intensities of peak 1 and 2 were both
dramatically increased. IS is the abbreviation of internal standard. Figures 1(b) and 1(c), the mass spectra for peak 1 and 2 in Figure 1(a),
revealed their identiﬁcations as trimethylsilyl derivatives of glutarate and 3-hydroxyglutarate, respectively.
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Figure 2: Chemical diagnosis of citrin deﬁciency by MS-MS analysis of amino and acyl carnitines in dried blood stain from a 16-month-
old male toddler (C0013) with syndromic GDD. Figures 2(a), 2(b),a n d2(c) are proﬁles of neutral loss scan, precursor scan, and multiple
reaction monitoring,respectively. The amino and acyl carnitines with increased levels were labeled as abbreviations, with Met, Tyr, Gly, Cit,
C0, C16, and C18:1 representing methionine, tyrosine, glycine, citrulline, free carnitine, palmitate, and hydroxypalmitate, respectively.4 Journal of Biomedicine and Biotechnology
Table 2: Etiology distribution in the whole cohort of NDDs.
Etiology categories Disease types Case number Proportion Concrete disease (case number)
Genetic diseases 50 102 35.8% Detailed informationin Table 3
Psychobehaviour 3 23 8.1% Autism (21, including 5 cases of Rett syndrome); ADHD (2)
Acquired brain injuries 2 7 2.4% Kernicterus (4); HIE (3)
Other etiology 2 15 5.3% Cerebral palsy (7), Epilepsy (8)
Unknown 1 (NDDs) 138 48.4% No concrete etiologies were identiﬁed at the current stage
In total 58 285 100% —
Table 3: Etiology distribution in the patients with genetic diseases in Table 2.
Etiology categories Disease types Case number Proportion Concrete diseases (case
number)
IEMs 27 66 64.7% Detailed informationin
Table 4
Congenital dysmorphic diseases 14 22 21.6% Detailed informationin
Table 5
Chromosomalabberations 4 6 5.9% Detailed informationin
Section 3.5
Endocrine disorders 3 4 3.9%
Hypoparathyroidism (1),
Pseudohypoparathyroidism
(1), Congenital
hypothyroidism (2)
Others 2 4 3.9%
Congenital muscular
dystrophy (3), Progressive
muscular dystrophy (1)
In total 50 102 100% —
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Figure 3: PCR-gel electrophoresis analysis of mutation 851del4
in the gene SLC25A13 of the two families with citrin-deﬁcient
patients C0013 and C0016. NC, Homo C and Hetero C in this
ﬁgure are abbreviations of Normal Control, Homozygous Control
andHeterozygousControl, respectively. F andM in thetwo families
represent Father and Mother, respectively. The 78bp PCR products
in both patients are 4bp shorter than the normal size 82bp,
suggesting that the 2 patients are both 851del4 homozygotes, and
their parents all carriers of the same mutation.
2.7. Electronic Microscopy. The muscular ultrastructure
changes were observed by transmission electronic micros-
copy in patients suspected to have Leigh syndrome and
muscular dystrophy, with biopsy samples from musculi
gastrocnemius. Muscular tissue was ﬁxedin 2.5%glutaralde-
hyde and post-ﬁxed in 1% osmium tetroxide solution, and
then embedded in epoxy resin before semithin sectioning,
as described in reference [10]. Two electronic microscope
instruments (JOEL-CX100 and Philips-Tecai-10) were uti-
lized for ultrastructure observation in our investigation.
This study was performed with the informed consents
from the parents of the patients, adhering to the principles
of the Declaration of Helsinki. In particular, SLC25A13
mutation analysis has been approved by the Committee
for Medical Ethics in the First Aﬃliated Hospital, Jinan
University, while chromosome karyotype analysis by that in
Reproductiveand Genetic Hospital ofCitic-Xiangya, Central
South University.
3.Results
3.1. General Information and Semiology. The NDDs cohort
in this study was composed of 285 cases in total, including
191 males and 94 females. The median age at referral was 1
year and 7 months, with minimum 1 week, and maximum
16 years. The whole cohort included 240 syndromic and
45 nonsyndromic NDD cases, with the relative proportion
of 84.2% and 15.8%, respectively. The main clinical man-
ifestations besides NDD and the laboratory and imaging
ﬁndings in the syndromic NDDs were summarized in
Table 1.
3.2. Etiology Distribution. As shown in Table 2,n oc o n c r e t e
etiologies, unfortunately, were found for 48.4% of the
total patients, but NDDs in the remaining 51.6% could
be attributed to complex and diverse etiologies, among
which genetic diseases were on top of the list of the
identiﬁed causes. Further analysis in Table 3 revealed that
IEMs took the ﬁrst place in genetic etiologies, and then came
congenitaldysmorphicdisorders.These2entitiesconstitutedJournal of Biomedicine and Biotechnology 5
Table 4: Feature of etiology distribution in the patients with IEMs in Table 3.
Categories Diseases∗ Cases Major diagnostic evidences Clinical outcomes
Disorders of
Carbohydrate
metabolism
Galactosemia 1
Clinical features including congenital
cataract and leukodystrophy, and
GC-MS analysis
Lost contact
Fructosuria 2 GC-MS analysis Both lost contact
Disorders of
Amino acid
metabolism
Phenylketonuria 7 GC-MS analysis in 6 cases, and PAH
gene analysis in 1 case
Referred to local network of
managementand 2 died after
treatment withdrawal
Histidinemia 1 Repeated MS-MS analysis Lost contact
Hyperhomocysteinemia 2 Total plasma homocysteine levels and
MS-MS analysis
1 died, and 1 stable without obvious
clinical or biochemical improvement
Pyroglutamic acidemia 1 GC-MS analysis Lost contact
Tyrosinemia type I 1 GC-MS and MS-MS ﬁndings Died due to acute liver failure
Hyperglycinemia 1 GC-MS and MS-MS analysis Intractable seizures and behavioral
problem
Canavan’s disease 1 GC-MS analysis Lost contact
Organic
acidemia
Methylmalonic acidemia 11
GC-MS, MS-MS and MMACHC gene
analysis,with 5 combined with
hyperhomocysteinemia
5 died after withdrawal of treatment, 3
improved and 3 lost contact
Maple syrup urine disease 2 GC-MS and MS-MS analysis Both died
Ethylmalonic acidemia 1 GC-MS analysis Lost contact
Propionic acidemia 3 GC-MS analysis 2 stable with episodic
hyperammonemia,and 1 lost contact
Glutaric acidemia type I 2 GC-MS and MS-MS analysis 1 lost contact and 1 stable
Glutaric acidemia type II 1 GC-MS analysis Stable
2-hydroxyglutaric acidemia 1 GC-MS analysis Lost contact
4-hydroxybutyric aciduria 1 GC-MS and ALDH5A1 gene analysis Stable but with seizure episodes
Multiple carboxylase deﬁciency 4 GC-MS, biotinidase activity, and
HLCS gene analysis 1 died, 3 recovered/improved clinically
Urea cycle
disorders
OTCD 2 GC-MS and MS-MS analysis Recovered clinically
Hyperammonemia 4
Markedly increased serum ammonia
levels, but with etiologies
undetermined yet
All lost contact
Citrin deﬁciency 2 SLC25A13 mutation analysis 1 died due to liver cirrhosis, 1
improved
Mitochondrial
disease Leigh syndrome 5
Clinical and imaging features,
serum/CSF lactate levels, and
electronic microscopy ﬁndings on
muscle biopsy samples
3 died already, and the remaining 2
stable at follow-up
Lysosome
storage
diseases
Mucopolysaccharidosis type I 1 Typical clinical manifestations Improved after bone marrow
transplantation
Mucopolysaccharidosis type II 2 Activity analysisof
iduronate-2-sulphatase Lost contact
Peroxisomal
disorders X-linked adrenoleukodystrophy 2
Clinical manifestations,CT/MRI
ﬁndings, and MS-MS analysis of
VLCFA
Both Died
Others Glyceroluria 4 GC-MS analysis 1 died after severe infection, 3 lost
contact
3-aminoisobutyricaciduria 1 GC-MS analysis Lost contact
∗Some diseases have been reported in [6] as GC-MS screening results, and this list herein is the latest update of our ﬁndings, just focusing on the IEMs
associated with NDDs.6 Journal of Biomedicine and Biotechnology
(a) (b)
(c) (d)
Figure 4: Representative MRI ﬁndings in diﬀerent malformations of cortical development (MCD). Figures 4(a) and 4(b) showed severe
cortex dysplasia in bilateral parietal lobes and frontal, temporal and occipital lobes, respectively, in the telencephalon of a 5-month-oldmale
withNDD. Figure 4(c) demonstrated typical lissencephaly in a 9-month-old femalewith Miller-Dieker syndrome. The white matter volume
was decreased while the cortex was thick and smooth due to lack of enough sulcation, forming the so-called pachygyria malformation,and
the thickened and irregular cortex in Figure 4(d) revealed the cobblestone cortical malformationin a patient with muscle-eye-brain disease.
the overwhelming majority in the genetic diseases. Other
causes such as chromosome and endocrine abnormalities
were also identiﬁed, just accounting for a minority less than
14% in the total genetic etiologies.
3.3. IEMs. As listed in Table 4, 66 patients with IEMs of 27
types and 8 categories were diagnosed in this NDD cohort.
The traditional clinical, biochemical, and imaging ﬁndings
were indispensable during the diagnostic processes, however,
the applications of two metabolome tools, GC-MS and MS-
MS,were substantially helpful in theexploration ofthe NDD
etiologies in this study. Figure 1 demonstrated the diagnostic
evidences of glutaric acidemia type I by GC-MS analysis of
urine sample. In particular, we diagnosed 2 GDD patients
secondary to citrin deﬁciency. Figure 2 illustrated the
MS-MS ﬁndings suggestive of citrin deﬁciencyin a male tod-
dler(C0013)athisageof1yearand4months,whopresented
with persistent GDD due to prolonged hepatosplenomegaly
and recurrent ascites that progressed into lethal hepatic
encephalopathy at his age of 1 year and 10 months. GDD
was transient in another 7-month-old infant (C0016) with
neonatal intrahepatic cholestasis caused by citrin deﬁciency
(NICCD, OMIM #605814), who demonstrated catch-up
development after recovery of dyslipidemia and abnormal
liver function indices. As shown in Figure 3,m u t a t i o n
analysis of the causative gene SLC25A13 clearly conﬁrmed
their diagnosis of 851del4 homozygotes.
3.4. Congenital Dysmorphic Disorders. In this NDDs cohort,
14 kinds and 22 cases of congenital dysmorphic disordersJournal of Biomedicine and Biotechnology 7
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Figure 5: Chromosome abberation in a 6-year-old female with mental retardation (MR). High-resolution GTG-banding in Figure 5(a)
revealed the derivative chromosomes 7 and 9 (question mark), and their detailed identities were further illustrated by the results of FISH
analysis.Figure 5(b) showed four red signals in a metaphase, by means of utilization of whole chromosome 7 painting probe (WCP 7, red).
Thenormalchromosome7hadoneintactred signal,butthederivativechromosome7(arrow)hadtwodispersedred signals,andafragment
of chromosome 7(arrowhead) was inserted into a chromosome9, forming a derivative chromosome9. Similarly, FISH analysis with WCP 9
(red) in Figure 5(c) showed the normal chromosome 9 with intact red signal, the derivative chromosome 9 (arrow) with two dispersed red
signals, and the derivative chromosome 7 with a inserted fragment of chromosome 9 (arrowhead). Finally, the chromosome karyotype in
this patient was identiﬁed as 46, XX, ins (7;9) (p13; q32q22) inv(7) (p11.2 q11.23), ins (9;7) (q22; q22q32), ish ins(7;9) (WCP7+, WCP9+),
ins(9;7) (WCP7+,WCP9+).
were diagnosed. Most of them were, as shown in Table 5,
malformations of cortical development (MCD) such as
Miller-Dieker syndrome, Muscle-Eye-Brain disease, and iso-
lated lissencephaly sequence. Figure 4 demonstrated rep-
resentative MRI ﬁndings in the diﬀerent MCD types.
Other CNS malformations like Dandy-Walker syndrome
and spinocerebellar ataxia, and some rare syndromes
including Silver-Russell syndrome, Noonan syndrome,
Poland−Moebius syndrome, and Crisponi syndrome, were
also found in our clinical practice. To our knowledge, the
patientwith Crisponi syndrome reported hereistheﬁrst case
in China.
3.5. Chromosome Karyotypes. By traditional chromosome
analysis, karyotype abnormalities were found in 6 patients.
Among them, 3 patients were diagnosed as having Down’s
syndrome (trisomy 21) and 1 Patau’s syndrome (trisomy
13), respectively. The remaining 2 were both complex
karyotypes, with mos. 47, XX, +der (15) (pter→ ql4::q14→
pter) [11]/48, XX, +der (15) (pter→q14::ql4→pter)/×2
[12]. ish der(15)(WCP15+, UBE3A++,PML-) in 1 case, and
46, XX, inv ins (7;9) (p13; q32q22) inv(7) (p11.2 q11.23),
ins (9;7) (q22; q22q32), ish(7;9) (WCP7+,WCP9+), ins(9;7)
(WCP7+,WCP9+) in another, as illustrated in Figure 5.S o
f a ra sw ek n o w ,t h el a s tk a r y o t y p ei san o v e lo n et h a th a s
never been reported in any other references. The patient
with this novel abnormal karyotype was a 6-year-old female
with mental retardation. History inquiry revealed motor
retardation, and examination uncovered dysmorphic facial
features including hypertelorism, downward eyeslant, and
low-set ears, constituting a clinical phenotype of syndromic
NDD.
3.6. Endocrine and Other Genetic Disorders. As shown in
Table 3, endocrine and other genetic disorders also played
importantrolesinNDDdevelopmentinthiscohort.Figure 6
clearly demonstrated not only the muscular lesions on
electronic microscopy observation, but also the existence
of leukodystrophy in MRI which indicated the involvement
of central nervous system and thus explained in part
the neurodevelopmental retardation in the patient with
congenital muscular dystrophy. It is also noteworthy that
a hypothyroidism patient in this study was combined with
hypophosphatasia withremarkable delayinboneossiﬁcation
as the radiological feature due to the reduced activity of
alkaline phosphatase. To our knowledge, the combined
clinical spectra of hypothyroidism and hypophosphatasia in
the same patient, once again, have never been reported in
other references.8 Journal of Biomedicine and Biotechnology
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Figure 6: Muscular ultrastructure and brain MRI ﬁndings in a patient with congenital muscular dystrophy. In Figure 6(a),t h em y o ﬁ b r i l
Z lines in a muscle cell were ruptured (↑), and the ﬁlaments between Z lines were arranged disorderly (
￿). Figure 6(b) showed the fatty
degeneration of myoﬁbrils (∗) in a muscle cell with completely vanished sarcolemma, and large quantity of collagenous ﬁbers (
￿)w e r e
observed in the endomysium (Bar = 1μm). Figures 6(c) and 6(d) were cranial MRI ﬁndings revealing the reduced signal intensity in T1WI
while increased one in T2WI, respectively, in bilateral frontal and parietal lobes, both indicating leukodystrophy.
4.Discussion
The ﬁndings in this study provided the latest clinical
epidemiology information on the etiology distribution of
NDDs in Chinese children. As shown in Table 2,n e a r l y
half of the NDD cases could not be attributed to con-
crete etiologies. This ﬁnding indicated the current issue
or challenge that we are facing and was consistent with
the well-known fact that the etiologies in a substantial
percentage of NDDs patients are undiagnosed even after a
comprehensive evaluation [13]. On the other hand, concrete
etiologies were identiﬁed for 51.6% of the total NDD cases,
and the etiology distribution in this cohort demonstrated
a rather heterogeneous feature. Autism spectrum disorders
(ASDs) have been well recognized as pervasive NDDs
entities, and there have been evidences suggesting that
some genes or chromosomal abberations are associated with
ASDs [14–16]. However, genetic studies have not provided
substantial insight into the 90% of cases of autism whose
cause is idiopathic, and the relative genetic contribution
to a susceptibility to autism from de novo mutations, rare
mutations, and common polymorphisms has been debated
extensively [17]. Therefore, autism was categorized into
psychobehavioraldisordersotherthangeneticdiseasesinthis
paper. This investigation also found 7 NDD cases caused
by kernicterus and hypoxemic and ischemic encephalopathy
(HIE) which were secondary to 2 curable and even pre-
ventable diseases, hyperbilirubinemia and birth asphyxia,
respectively. The existence of these 7 cases further suggested
the brain vulnerability to exogenous injuries in children,
especially in fetuses and neonates. We also found cerebral
palsy and epilepsy as NDD etiologies in this NDD cohort,
with several cases of refractory epilepsy. However, it is
noteworthy that, considering the brain vulnerability once
again and the possible eﬀects of antiepileptic drugs (AEDs)
on neurodevelopment [18, 19], every child with epilepsy
must be evaluated on an individual basis as to the risk and
beneﬁt of any particular AED used and the role of ongoing
treatment [20].
In this eight-year clinical study, various laboratory tech-
nologieswereconductedintheﬁeldsofclinicalbiochemistry,
neuroimaging, biochemicalgenetics,cytogenetics,molecularJournal of Biomedicine and Biotechnology 9
Table 5: Congenital dysmorphic disorders in the patients with genetic diseases in Table 3.
Disorders Cases Main clinical/imagingfeatures
Cortical dysplasia 1
Motor developmental retardation and microcephaly. Severe cortex dysplasia
in parietal lobe and frontal, temporal and occipital lobes, respectively, on
cranial MRI scanning.
Tuberous sclerosis 1
Intelligence and motor retardation, seizures, cutaneous hypomelanotic
macules, fondus ocili depigmentation, and subependymal nodules and
calciﬁed lesions in the cortex of parietal and temporal lobes on cranial CT
scanning
Miller-Dieker syndrome 2
Intelligence and motor retardation, microcephaly, prominent occiput, narrow
forehead, small nose and chin. Seizure in 1 case and hypertonia in another
one. Agyria/pachygyria cortical malformationson MRI.
Muscle-Eye-Brain disease 2
Sibling sisters with global developmental delay. Abnormal pupils and vitreous
bodies in both cases on ophthalmologicexamination. Convulsions in 1 case
and small right eyeball in another. Both have increased creatine kinase levels
and cobblestone cortical malformationson MRI.
Isolated lissencephaly sequence 1 Intelligence and motor retardation, and bilateral thickened and irregular
cortex on MRI
Lissencephaly with cerebellar hypoplasia 1 Mental/languageretardation, drooling, and bilateral pachygyria
malformationand hypoplasia of cerebellum revealed by MRI.
Other malformationsof cortical development 6 All have intelligence and motor retardation. Including 2 cases of cobblestone
cortical malformationsand 1 classic lissencephaly revealed by CT/MRI.
Dandy-Walker syndrome 1
Intelligence and motor retardation with low-set and everted ears, and
hypoplasia and upward rotation of the cerebellar vermis and cystic dilation of
the fourth ventricle on MRI.
Spinocerebellar ataxia 1
Intelligence and motor retrogression, and severe cerebellar and pons atrophy
together with tiger-eye-like sign at the basal ganglia level and cross-sign at
pons level, respectively, on MRI.
Neuroﬁbromatosis type I 1 Intelligence and motor retardation, and 7 cutaneous cafe-au-lait patches with
diameter over 10mm
Silver-Russell syndrome 2
Both have dysmorphic facial features including triangular face, low-set ears,
ﬂat nasal bridge with extroversion of nostrils and down-curving mouth
corners. Normal head circumference. Asymmetry of the lower extremities.
Postnatalfailure to thrive. Intrauterine retardation in 1 case and linea alba
hernia in another.
Noonan syndrome 1
Short stature, short neck with redundancy of skin, hypertelorism, downward
eyeslant, low-set ears, cryptorchidism, and poor sucking. Atrial septal defect
and right pulmonic stenosis on ultrasonography.
Poland−Moebius syndrome 1
Signs of facial palsy, disappeared corneal reﬂex, and poor sucking and
swallowing.Micrognathia and high-arched palate. Smallleft hand, ipsilateral
brachydactyly and hypoplasia of the nails and pectoralis major muscle.
Crisponi syndrome 1
Convulsions in response to stimuli like crying and bathing. Camptodactyly in
hands. Round face, broad nose with anteverted nostrils, and micrognathia.
Major sucking diﬃculty and frequent apnea. Hyperthermia that led to death.
genetics, and electronic microscopy as well. Our experiences
strongly supported the viewpoint that detailed history
inquiry and physical examination are paramount in the
evaluation of NDDs, while judicious investigations can
be useful adjunct in determining etiology [21]. As the
commonest etiology category in this NDD cohort, genetic
diseases, as shown in Table 3, also covered a wide proﬁle
of diﬀerent entities, with IEMs on top of the list. The
application of two metabolomic technologies, GC-MS and
MS-MS, played irreplaceable roles in the identiﬁcation
of various IEM entities in this study (Table 4). Although
other skills such as enzymatic activity and gene mutation
analysis help us to conﬁrm the diagnosis of IEM in some
cases, selective screening for IEMs by means of GC-MS
and MS-MS provides the basis or prerequisite for further
intensive investigation. The clinical application of these
metabolomic tools in mainland of China was initiated from
the beginning of this century, however, their indispensable
function in chemical diagnosis of IEMs has been aﬃrmed by
more and more clinical evidences in our pediatric practice
[6, 22, 23]. Actually, mass spectrometry has occupied an
increasingly prominent place in clinical chemistry and
laboratory diagnostics during the past few decades [24], and
nowadays has been recognized as one of the most frequently10 Journal of Biomedicine and Biotechnology
employed methods of detection in the ﬁeld of metabolome
[25]. However, the metabolomic technologies including GC-
MS and MS-MS analysis in this study sometimes yields
nonspeciﬁc and nondiagnostic abnormalities. An example is
the metabolome feature of NICCD. This entity was prone to
be misdiagnosed as tyrosinemia or galactosemia in case just
based on the GC-MS and/or MS-MS ﬁndings [26, 27].
Citrin deﬁciency and a rare chromosome karyotype were
found in this study as novel causes for GDD and MR,
respectively, further expanding the etiology proﬁle of NDDs.
Many “new” IEMs have been discovered in the recent years,
and some of themhave been found to have features ofNDDs
[28]. Citrin deﬁciency, ﬁrst described in Japan and East Asia,
is a newly-established IEM now considered as a panethnic
disease distributed worldwide [27, 29]. We have no direct
evidence to explain why the 2 citrin-deﬁcient patients in this
study presented with syndromic GDDs. However, their GDD
manifestations could not be explained with brain injury
directly due to deﬁcient citrin, since this aspartate/glutamate
carrier (AGC) is predominantly found in liver, kidney, heart,
and intestine, but not in brain [29]. Interplay of multiple
factors may represent the possible underlying mechanism.
For example, secondary galactosemia and tyrosinemia in
citrin deﬁciency, including the 2 cases in this paper, are quite
common [26, 27], and brain injuries caused by disturbances
in the metabolism of galactose and tyrosine have been
reported [12, 30]. The detailed mechanism(s) for the child
with novel karyotype to develop MR remains unclear at the
current stage. However, the chromosome aberration in this
patient produced 4 chromosome breakpoints, changing the
genome architecture inevitably, and thus the syndromic MR
may result from one or more mechanisms including gene
interruption, gene fusion, position eﬀect, unmasking of a
recessive allele, presence of a functional polymorphism, and
genetransvection eﬀect[11, 31], asproved in otherdisorders
ofgenomearchitecture suchasacutelymphoblasticleukemia
[32] and retinitis pigmentosa [33].
5.Conclusions
Although the etiologies in nearly half of the patients still
remain an unresolved issue in this NDD cohort, genetic
diseases including IEMs and congenital dysmorphic diseases
constituted the commonest identiﬁed etiology category. GC-
MS and MS-MS, the two key experimental technologies in
the ﬁeld of pediatric metabolomics, proved to be substan-
tially helpful for the exploration of the NDD etiologies in
our clinical practice. The ﬁndings in this paper provided
latestepidemiologicinformation ontheetiologydistribution
of NDDs in Chinese, and syndromic NDDs caused by
citrin deﬁciency and the novel chromosomal karyotype,
respectively, further expanded the etiology spectrum of
NDDs.
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